tiprankstipranks
PharmaCielo (PCLOF)
OTHER OTC:PCLOF
Holding PCLOF?
Track your performance easily

PharmaCielo (PCLOF) Technical Analysis

85 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Buy
3Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
PharmaCielo’s (PCLOF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting PharmaCielo is a Sell.
PharmaCielo’s (PCLOF) 20-Day exponential moving average is 0.06, while PharmaCielo’s (PCLOF) share price is <$0.1, making it a Sell.
PharmaCielo’s (PCLOF) 50-Day exponential moving average is 0.08, while PharmaCielo’s (PCLOF) share price is <$0.1, making it a Sell.

PharmaCielo (PCLOF) Pivot Points

Nov 26, 2024, 05:21 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Fibonacci
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

PharmaCielo (PCLOF) Moving Averages

Nov 26, 2024, 05:21 AM
Period
Simple
Exponential
MA5
0.06Sell
0.06Sell
MA10
0.06Buy
0.06Sell
MA20
0.06Sell
0.06Sell
MA50
0.08Sell
0.08Sell
MA100
0.09Sell
0.09Sell
MA200
0.11Sell
0.11Sell
PharmaCielo’s (PCLOF) 10-Day exponential moving average is 0.06, while PharmaCielo’s (PCLOF) share price is <$0.1, making it a Sell.
PharmaCielo’s (PCLOF) 100-Day exponential moving average is 0.09, while PharmaCielo’s (PCLOF) share price is <$0.1, making it a Sell.
PharmaCielo’s (PCLOF) stock price is <$0.1 and PharmaCielo’s (PCLOF) 50-day simple moving average is 0.08, creating a Sell signal.
PharmaCielo’s (PCLOF) stock price is <$0.1 and PharmaCielo’s (PCLOF) 100-day simple moving average is 0.09, creating a Sell signal.
PharmaCielo’s (PCLOF) stock price is <$0.1 and PharmaCielo’s (PCLOF) 200-day simple moving average is 0.11, creating a Sell signal.

PharmaCielo (PCLOF) Technical Indicators

Nov 26, 2024, 05:21 AM
Name
Value
Implied Action
RSI (14)
44.84
Neutral
STOCH (9,6)
36.55
Neutral
STOCHRSI (14)
26.32
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
14.88
Buy
Williams %R
-73.68
Buy
CCI (14)
-18.45
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
42.33
Neutral
ROC
0.00
-
PharmaCielo’s (PCLOF) Relative Strength Index (RSI) is 44.84, creating a Neutral signal.
PharmaCielo’s (PCLOF) Trend Strength Indicator (ADX) is 14.88, creating a Buy signal.
PharmaCielo’s (PCLOF) Commodity Channel Index (CCI) is -18.45, creating a Neutral signal.

FAQ

Is PCLOF a Buy, Hold, or Sell?
Based on PCLOF’s technical indicators, PCLOF is a Sell.
    What is PCLOF’s RSI (14)?
    PCLOF’s RSI (14) is 44.84, which suggests PCLOF is a Neutral.
      What is PCLOF’s MACD?
      PCLOF’s MACD is >-0.01, which suggests PCLOF is a Sell.
        What is PCLOF’s 5-day moving average?
        PCLOF’s 5-day moving average is 0.06, which suggests PCLOF is a Sell.
          What is PCLOF’s 20-day moving average?
          PCLOF 20-day moving average is 0.06, which suggests PCLOF is a Sell.
            What is PCLOF’s 50-day moving average?
            PCLOF’s 50-day moving average is 0.08, which suggests PCLOF is a Sell.
              What is PCLOF’s 200-day moving average?
              PCLOF’s 200-day moving average is 0.11, which suggests PCLOF is a Sell.
                What is PCLOF’s Williams % R (14)?
                PCLOF’s Williams % R (14) is -73.68, which suggests PCLOF is a Buy.
                  What is PCLOF’s CCI (14)?
                  PCLOF’s CCI (14) is -18.45, which suggests PCLOF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis